"/> Tocris Bioscience™ GLYX 13 | B-LABO France

Tocris Bioscience™ GLYX 13

Réf. : BL-RE-052672Réf. fabricant : 18034112 1 mg
226,87 € HT

NMDA receptor partial agonist; acts at the glycine site

Pureté
0.95
Quantité
1 mg
Marque
Tocris Bioscience

GLYX 13 is a NMDA receptor partial agonist that acts at the glycine site. Simultaneously acts as a promoter of the induction of long-term potentiation (LTP) and as a suppressor of long-term depression (LTD). Also promotes VGF and BDNF release and increases ERK/mTOR signaling . Exhibits nootropic, neuroprotective and antinociceptive activity, and enhances learning, memory and cognition

in vivo

. Brain penetrant.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-052672
Réf. fabricant18034112
Pureté0.95
Quantité1 mg
Une question, une configuration particulière ?
Contactez-nous pour un devis.